Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel enzyme catalytic system synthesizes organic selenides greenly. Offers supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing without heavy metals.
Patent CN106892950B reveals a green route to >98% Troxerutin using sodium alginate, offering cost-effective API intermediate manufacturing.
Patent CN116103255A details engineered KdAKR mutants for high-yield synthesis of tert-butyl 6-chloro-(3R,5S)-dihydroxyhexanoate, offering superior stereoselectivity and thermal stability for statin production.
Patent CN115521961A reveals high-efficiency alpha-amino acid ester acyltransferase for L-Alanyl-L-Glutamine production, offering superior conversion rates and cost-effective manufacturing solutions.
Patent CN117887739A reveals enzymatic route for moxifloxacin intermediate offering cost reduction and high purity for pharmaceutical manufacturing supply chains.
Patent CN112941116A details a novel enzymatic route for alpha-ketoglutarate calcium, offering superior purity and cost reduction in pharmaceutical manufacturing.
Patent CN114657164B reveals a novel enzymatic route for L-glufosinate, offering superior purity and cost efficiency for agrochemical intermediate supply chains.
Patent CN104498510A enables enzymatic synthesis of atorvastatin side chain with superior stereoselectivity and scalable fermentation processes for global supply chains.
Patent CN110564755B details a novel enzymatic route for (S)-3-phenyl-1,2-epoxypropane. Discover cost-effective, metal-free manufacturing solutions for high-purity API precursors.
Patent CN117625571A reveals high-tolerance ketoreductase for ezetimibe intermediate. Enhances purity and reduces manufacturing costs for pharmaceutical supply chains.
Patent CN115109760A discloses engineered monoamine oxidase for Boceprevir and Nirmatrelvir intermediates, offering superior catalytic efficiency and cost-effective manufacturing solutions.
Patent CN108715881B reveals a dual-enzyme route for pregabalin intermediates. Achieve 99.5% e.e. and simplified processing for cost-effective API manufacturing.
Patent CN110229796B details enzymatic synthesis for high-purity duloxetine intermediates. Offers cost reduction and supply chain reliability for pharma manufacturing.
Patent CN110951799A reveals a novel whole-cell enzymatic route for high-purity (2S,3R)-p-methylsulfonylphenylserine, offering significant cost reduction and scalable green manufacturing for antibiotic intermediates.
Patent CN115109759A reveals engineered carbonyl reductases achieving 600g/g S/C ratio. Discover cost-effective biocatalytic routes for chiral alcohol production.
Patent CN113234696B details a novel in vitro enzymatic route for crocetin from zeaxanthin, offering superior purity and scalable production for fine chemical manufacturing.
Patent CN106978368B details a novel nitrilase biocatalysis route for L-glufosinate precursors, offering high optical purity and reduced environmental impact for agrochemical manufacturing.
Patent CN106191150A details a co-immobilized enzymatic method for D-alanine. Achieves >98% purity with continuous 55-day operation, offering significant supply chain stability and cost reduction.
Patent CN109943542A reveals enhanced ADH for Atazanavir. Lower cost, green synthesis, high purity pharmaceutical intermediates for global supply chains.
Patent CN109576234B reveals a highly active V77A mutant enzyme enabling efficient biosynthesis of hydroxylated amino acids, offering significant cost reduction in API manufacturing and reliable supply chain solutions.